Up to 40 percent of vaccine courses from manufacturers might remain for low- and middle-income countries by end of 2021
Alaska HCW First in U.S. to Have Allergic Reaction to COVID-19 Vaccine
Worker felt flushed within 10 minutes of receiving vaccine, followed by shortness of breath and elevated heart rate
Advisory Committee Votes to Recommend EUA for Moderna Vaccine
Could become the second COVID-19 vaccine in a week to receive emergency use authorization
Suicide Mortality Up for Blacks During Closure Period of COVID-19
Mean suicide mortality increased among Black residents of Maryland but decreased among Whites from March 5 to May 7, 2020
Working From Home May Negatively Impact Physical, Mental Health
Majority of at-home workers report new physical and mental health issues
COVID-19 Linked to Increased All-Cause Mortality in Young Adults
4,535 COVID-19 deaths reported nationally among adults aged 25 to 44 years, accounting for 38 percent of excess mortality
Americans Showing Hesitancy Toward COVID-19 Testing
Majority of adults believing they need a COVID-19 test delay or avoid testing, most often due to exposure fear
Hyperglycemia, Hypoglycemia Linked to Poor Outcomes in COVID-19
Admission blood glucose is strong predictor of death among patients admitted directly to the ICU
One in Five Patients Hospitalized With COVID-19 Dies
Statins, angiotensin-converting enzyme inhibitors, and calcium channel blockers tied to lower risk for death
At-Home COVID-19 Test Authorized
The U.S. Food and Drug Administration announced it issued an emergency use authorization for the first over-the-counter (OTC) at-home diagnostic test for COVID-19.
The Ellume COVID-19 Home Test is a rapid, lateral flow antigen test that detects fragments of proteins from any individual 2 years of age or older.
The Ellume COVID-19 Home Test is the first COVID-19 test that can be used entirely at home without a prescription, says the FDA.